Aurobindo Pharma reported INR1.02B in Interest Expense on Debt for its fiscal quarter ending in September of 2026.





Interest Expense On Debt Change Date
Cipla INR 167.4M 2.9M Sep/2026
Divis Laboratories Ltd INR 130M 70M Sep/2026
Dr.Reddys Laboratories INR 1.26B 198M Jun/2026
Hindustan Unilever INR 760M 120M Mar/2026
Sun Pharmaceuticals INR 859M 139.6M Mar/2026
UPL INR 8.19B 170M Sep/2026